News & Updates

Depression, sleep disturbance tied to urinary symptoms in men with LUTS
Depression, sleep disturbance tied to urinary symptoms in men with LUTS
22 Jun 2022
Aminosalicylate use more common among older than younger IBD patients
Aminosalicylate use more common among older than younger IBD patients
22 Jun 2022

Use of medication is markedly different among older patients with inflammatory bowel disease (IBD), with more aminosalicylate monotherapy and less antitumour necrosis factor monotherapy than younger patients, according to a US study.

Aminosalicylate use more common among older than younger IBD patients
22 Jun 2022
What causes death in bladder cancer patients?
What causes death in bladder cancer patients?
22 Jun 2022 byTristan Manalac

Heart diseases, chronic obstructive pulmonary disease (COPD), concomitant cancers, and other co-occurring diseases elevate the risk of death in patients with nonmuscular invasive bladder cancer (NMIBC), nonmetastatic muscle invasive bladder cancer (non-MMIBC), and metastatic bladder cancer (MBC), according to a recent study.

What causes death in bladder cancer patients?
22 Jun 2022
NAFLD linked to heightened type 2 diabetes risk
NAFLD linked to heightened type 2 diabetes risk
22 Jun 2022

Children with nonalcoholic fatty liver disease (NAFLD) are at an increased risk of type 2 diabetes, a study reports. Other risk factors for T2D include severity of liver histology, body mass index, and female sex.

NAFLD linked to heightened type 2 diabetes risk
22 Jun 2022
Acute kidney injury tied to poorer stroke survival, subsequent CKD development
Acute kidney injury tied to poorer stroke survival, subsequent CKD development
22 Jun 2022

The presence of acute kidney injury (AKI) during stroke appears to contribute to increased mortality, with AKI tending to progress to chronic kidney disease (CKD) even without the need for renal replacement therapy, a study has found.

Acute kidney injury tied to poorer stroke survival, subsequent CKD development
22 Jun 2022
HBcrAg, HBsAb levels tied to persistent functional chronic hepatitis B cure
HBcrAg, HBsAb levels tied to persistent functional chronic hepatitis B cure
22 Jun 2022

In chronic hepatitis B (CHB) patients treated with pegylated interferon alpha (peg-IFN-α)-based interventions, lower levels of the HB core-related antigen (HBcrAg) and higher levels of the HB surface antibody (HbsAb) are associated with durable functional cure, a recent study has found,

HBcrAg, HBsAb levels tied to persistent functional chronic hepatitis B cure
22 Jun 2022